Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome
about
Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case report.How I treat refractory thrombotic thrombocytopenic purpura.Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
P2860
Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@ast
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@en
type
label
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@ast
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@en
prefLabel
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@ast
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@en
P2093
P2860
P356
P1476
Rituximab for managing relapsi ...... a--haemolytic uraemic syndrome
@en
P2093
Alessandra Malato
Domenica Caramazza
Gerlando Quintini
Giorgia Saccullo
Giuseppina Mazzola
Giuseppina Pizzo
Ignazio Abbene
Lucio Lo Coco
Rita Barone
Roberto Palazzolo
P2860
P304
P356
10.2450/2009.0101-09
P577
2010-07-01T00:00:00Z